Lipidated Peptidomimetic Ligand-Functionalized HER2 Targeted Liposome as Nano-Carrier Designed for Doxorubicin Delivery in Cancer Therapy
The therapeutic index of chemotherapeutic agents can be improved by the use of nano-carrier-mediated chemotherapeutic delivery. Ligand-targeted drug delivery can be used to achieve selective and specific delivery of chemotherapeutic agents to cancer cells. In this study, we prepared a peptidomimetic...
Main Authors: | Himgauri Naik, Jafrin Jobayer Sonju, Sitanshu Singh, Ioulia Chatzistamou, Leeza Shrestha, Ted Gauthier, Seetharama Jois |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/3/221 |
Similar Items
-
Recent Preclinical and Clinical Progress in Liposomal Doxorubicin
by: Kenan Aloss, et al.
Published: (2023-03-01) -
Morphological changes of doxorubicin-loaded liposomes observed by atomic force microscopy
by: Naoki Takahashi, et al.
Published: (2016-02-01) -
Transcriptome-wide elucidation of liposomal formulations for anticancer drug delivery
by: Huang, Bu-Wei, et al.
Published: (2018) -
Reduction of Doxorubicin-Induced Cardiotoxicity by Co-Administration of Smart Liposomal Doxorubicin and Free Quercetin: In Vitro and In Vivo Studies
by: Hamidreza Dorostkar, et al.
Published: (2023-07-01) -
Targeting the EGF receptor family in non-small cell lung cancer—increased complexity and future perspectives
by: Tobias Boch, et al.
Published: (2022-11-01)